20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Perfusion system
#6602Peritoneal dialysate, peritoneal dialysate set, composition used for peritoneal dialysis, and method for peritoneal dialysis
#6603Preparation of flagellin vaccine adjuvant-based vaccine to induce production of antibody recognizing conformation of antigens, and application thereof
#6604GNE as a therapeutic agent
#6605Use of IL-22 in treating necrotizing enterocolitis
#6606Inducing cell death by hyperactivation of motility networks
#6607TREATMENT OF DEGENERATIVE JOINT DISEASE
#6608COMPOSITIONS AND METHODS OF USING SAME FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#6609USE OF PLATELETS IN TREATING INFECTIONS
#6610Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6611PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#6612TREATMENT OF FIBROSIS WITH GENETICALLY-ENGINEERED MACROPHAGES
#6613Sodium nitrite-containing pharmaceutical compositions
#6614INJECTABLE COMPOSITION FOR THE TREATMENT OF MUSCULOSKELETAL DISORDERS AND METHODS OF USE THEREOF
#6615RNAi agents for hepatitis B virus infection
#6616Methods for Treatment of Alport Syndrome
#6617ANTICONVULSANT ACTIVITY OF STEROIDS
#6618Methods of administering intravenous meloxicam in a bolus dose
#6619Pharmaceutical composition of pemetrexed
#6620DOSING REGIMEN FOR INJECTABLE CETIRIZINE
#6621Dosing regimen for injectable cetirizine
#6622Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
#6623Compositions for the treatment of drug-resistant tumors and methods of use thereof
#6624BIORESPONSIVE HYDROGEL MATRIXES AND METHODS OF USE
#6625Injectable Suspensions
#6626Use of MIR101 or MIR128 in the treatment of seizure disorders
#6627METHOD AND SYSTEM FOR HAIR REGROWTH USING 3D ORGANOID SYSTEM OF HAIR FOLLICLE STEM CELL
#6628Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2
#6629METHOD OF INHIBITING ECTOPIC CALCIFICATION
#6630Subcutaneous formulations of anti-CD38 antibodies and their uses
#6631METHODS FOR TREATING LATE-ONSET ASTHMA USING BENRALIZUMAB
#6632PACAP antibodies and uses thereof
#6633Immunoglobulins and uses thereof
#6634METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES
#6635METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
#6636Pharmaceutical co-crystal composition and use thereof
#6637COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#6638RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF
#6639Bioactive polymer for bone regeneration
#6640Cyanobacterium extracellular polymer, compositions and uses thereof
#6641COLLOIDAL PARTICLES FOR USE IN MEDICINE
#6642Antibody compositions
#6643METHODS FOR THE PREDICTION OF A PERSONALIZED ESA-DOSE IN THE TREATMENT OF ANEMIA
#6644Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof
#6645Sincalide Formulations
#6646COMPOSITIONS AND METHODS OF TREATING CANCER USING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS
#6647Placental tissue component compositions for treatment of skin defects and methods using same
#6648Trace element solution
#6649Composition for preventing or improving menopausal symptom comprising novel ginsenoside
#6650STABLE AQUEOUS PARENTERAL SOLUTIONS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)
#6651Chemical Compounds as ATF-4 Pathway Inhibitors
#6652SYSTEMS AND METHODS TO TREAT PAIN LOCALLY
#6653Storage stable aqueous parenteral solutions comprising diclofenac
#6654METHOD OF REDUCING NEURONAL CELL DEATH WITH HALOALKYLAMINES
#6655METHOD FOR TREATMENT OF PARKINSON'S DISEASE
#6656Method for making injectable pharmaceutical compositions
#6657NOVEL FORMULATIONS OF VASOPRESSIN
#6658METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS
#6659Anti-NRP1A antibodies and their uses for treating eye or ocular diseases
#6660APPLICATION OF TACI-FC FUSION PROTEIN IN PREPARATION OF DRUGS FOR TREATING NEUROMYELITIS OPTICA SPECTRUM DISORDERS AND MULTIPLE SCLEROSIS
#6661Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic
#6662COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#6663Insoluble complex or solvate thereof, pharmaceutical composition and use thereof
#6664ENHANCEMENT OF PATHOGEN IMMUNOGENICITY
#6665Injectable preparation
#6666Liquid Protein Formulations Containing Viscosity-Lowering Agents
#6667Combination treatment of chemoresistant cancers
#6668UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
#6669GLP-1 compositions and uses thereof
#6670Oncolytic viral delivery of therapeutic polypeptides
#6671Preparation and application of grain worm for treating diabetes
#6672CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR TREATMENT AND PREVENTION OF CANCER
#6673High elasticity hyaluronan compositions and methods of use thereof
#6674AGENTS, COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING ALZHEIMER'S DISEASE
#6675Stable pharmaceutical compositions of dihydroergotamine mesylate
#6676METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
#6677Long-acting formulations
#6678Lyophilized compositions of phenobarbital sodium salt
#6679Injectable pharmaceutical formulation
#6680SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS
#6681Compositions and methods for treating severe pain
#6682AAV vectors encoding clarin-1 or GJB2 and uses thereof
#6683TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS DELIVERED BY LIPID NANOPARTICLES
#6684Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
#6685Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6686DOSING REGIMES FOR TREATMENT OF SYNUCLEINOPATHIES
#6687DOSING OF A BISPECIFIC ANTIBODY THAT BINDS PD1 AND CTLA4
#6688SYSTEMS AND METHODS FOR LOCAL MODULATION OF WNT SIGNALING
#6689Compositions for Treating Amyloidosis
#6690Peptide hydrogels and use thereof
#6691COMPOSITIONS AND METHODS FOR THE SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS
#6692Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers
#6693Modulators of PCSK9 expression
#6694METHOD OF TREATING CANCER
#6695Citrate buffered VEGF antagonist formulations
#6696Multivalent pneumococcal polysaccharide-protein conjugate composition
#6697Intervention device
#6698COMBINATION THERAPY FOR THE TREATMENT OF MIGRAINES
#6699METHOD FOR PREVENTING OR TREATING OSTEOPOROSIS, CHARACTERIZED BY ADMINISTERING TERIPARATIDE OR SALT THEREOF AT A FREQUENCY OF TWICE A WEEK
#6700STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
#6701GENOTYPE STRATIFICATION IN DIABETES TREATMENT AND PREVENTION
#6702TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#6703BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER
#6704Modulators of complement activity
#6705PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS
#6706Manufacture of Degarelix
#6707Treating Autoimmune Disorders with Acetylcholinesterase Inhibitors
#6708Methods of Neoplasm Treatment Utilizing Complementary Oncolytic Viruses and CAR T-Cells
#6709Therapeutic bacteriophage compositions for treating infection
#6710Use of genetically engineered bacterium of attenuated in for treating liver cancer
#6711Methods and compositions for treatment of penile defects
#6712Method for bone tissue regeneration in experiments
#6713Linear glycosidase inhibitors
#6714Antibiotic combination therapies
#6715Rifabutin treatment methods, uses, and compositions
#6716Rifabutin treatment methods, uses, and compositions
#6717Ophthalmic compositions including levodopa, an antioxidant and an aqueous carrier
#6718Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same
#6719COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) FOR JOINT STABILITY
#6720Analgesic formulation for control of pain in dogs
#6721Biodegradable polymer microsphere compositions for parenteral administration
#6722Prodrug compositions, prodrug nanoparticles, and methods of use thereof
#6723Liposomes comprising sphingomyelin
#6724ANTIBODY AND PROTEIN FORMULATIONS
#6725Method of administering sotalol IV/switch
#6726Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#6727OPTIMIZED ANTI-TL1A ANTIBODIES
#6728Methods for treating late-stage small cell lung cancer by administering a human anti-PD-L1 antibody, an etoposide and a platinum-based therapeutic
#6729Anti-IL-23p19 Antibody Formulations
#6730Compositions and methods for the treatment of carboxyhemoglobinemia
#67312-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
#6732Method of using adeno-associated virus with variant capsid
#6733Adeno-associated virus variant capsids and methods of use thereof
#6734CNP PRODRUGS
#6735PHARMACEUTICAL FORMULATIONS
#6736METHODS AND COMPOSITIONS FOR TUMOR RADIOSENSITIZATION
#6737Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota
#6738VLP stabilized vaccine compositions
#6739Lyophilized factor IX formulations
#6740MODIFIED FACTOR VII POLYPEPTIDES FOR SUBCUTANEOUS ADMINISTRATION AND ON-DEMAND TREATMENT
#6741Use of pertussis toxin as a therapeutic agent
#6742Methods and compositions for treating muscle disease and disorders
#6743Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device
#6744Heterotandem bicyclic peptide complex
#6745COMBINATION THERAPY USING ADOPTIVE CELL THERAPY AND CHECKPOINT INHIBITOR
#6746Methods of making novel pharmaceutical compositions
#6747Composition for treating joint disease and kit containing same
#6748Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#6749TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#6750Methods for treating acute myeloid leukemia and related conditions
#6751COMPOSITION AND METHOD OF TREATMENT FOR DRY A.M.D. (AGE RELATED MACULAR DEGENERATION)
#6752Mirtazapine as a pre-shipping inhibitor of bovine respiratory disease
#6753BACE1 inhibition for the treatment of cancer
#6754Composition containing piperacillin, pharmaceutical formulation thereof and use thereof
#6755Treating Autoimmune Disorders with Chloroquine and/or Hydroxychloroquine
#6756Gingko diterpene lactone composition
#6757Treatment of disease with n-acetyl kynurenine
#6758IMPROVED IMMUNOTHERAPY
#6759PLASMID CONSTRUCTS FOR HETEROLOGOUS PROTEIN EXPRESSION AND METHODS OF USE
#6760Methods and compositions for inhibiting expression of LDHA
#6761Dosing Regiments of Bi-Specific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies
#6762GIPR antibody and GLP-1 fusion protein thereof, and pharmaceutical composition and application thereof
#6763USE OF ANTI-IL-36R ANTIBODIES FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
#6764DOSING REGIMENS FOR TARGETED TGF-B INHIBITION FOR USE IN TREATING CANCER IN TREATMENT NAÏVE SUBJECTS
#6765Influenza virus replication for vaccine development
#6766Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#6767Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#6768COMPOUNDS FOR TREATING EYE DISEASES AND METHODS THEREOF
#6769Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione
#6770Lipid nanoparticle compositions and methods for mRNA delivery
#6771METHODS OF IMMUNOSTIMULATION WITH COMPLEXES OF RNA AND CATIONIC CARRIERS
#6772VACCINE FOR TREATMENT OF CANCER AND METHOD OF MAKING BY STRESS REPROGRAMMING
#6773NOVEL ADENOVIRUS
#6774Nanospheres for bone fracture
#6775Rapid-acting insulin formulation comprising a substituted anionic compound
#6776Method for treating cerebral stroke
#6777Oncolytic virus improved in safety and anticancer effect
#6778CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB
#6779COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
#6780COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
#6781Ameliorating nervous systems disorders
#6782Pharmaceutical composition comprising particles and methods of making same
#6783Sting agonists for treating bladder cancer and solid tumors
#6784Liquid polymer delivery system for extended administration of drugs
#6785Use of minaprine to reduce tumor growth
#6786DNA-PK inhibitors
#6787THERAPEUTIC DRUG FOR DYSKINESIA
#6788ORGANIC COMPOUNDS
#6789TREATMENT OF CANCER
#6790Use of I-BRD9 or derivatives thereof in preparing anti-epileptic drugs
#6791Alpha-aminoadipate for treatment of vision loss and restoring sight
#6792Nanoparticles for treatment of posterior segment ocular diseases and conditions
#6793Method for producing freeze-dried formulation
#6794Dry Transfection Compositions and Methods for Making and Using the Same
#6795HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS
#6796TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRB ANTIBODY
#6797Formulations of antibody molecules to influenza virus
#6798Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering
#6799Treprostinil prodrugs
#6800Inhibitors of cyclin-dependent kinases
#6801Crystalline forms of Actinomycin D for treatment of cancer
#6802POLYMORPHIC FORMS OF (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE
#6803BIODIFFUSION CHAMBER
#6804Therapeutic applications of artificial cerebrospinal fluid and tools provided therefor
#6805MESENCHYMAL STEM CELLS OR STROMAL CELLS HARBORING MODIFIED RNAS ENCODING VEGF AND BMP POLYPEPTIDES
#6806Selective hydrogen sulfide probe and uses thereof
#6807Hydrogel prodrug for treatment
#6808Methods for treatment using anti-alpha4beta7 antibody
#6809ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER
#6810ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#6811Tuberculosis vaccine, preparation method therefor, and use thereof
#6812HETEROLOGOUS COMBINATION PRIME:BOOST THERAPY AND METHODS OF TREATMENT
#6813GLP-1 COMPOSITION FOR TREATING OBESITY AND WEIGHT MANAGEMENT
#6814Compositions and methods for subcutaneous administration of cancer immunotherapy
#6815COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISORDERS USING LACHNOSPIRACEAE BACTERIA
#6816TREATMENT OF INTERVERTEBRAL DISC DEGENERATION
#6817TREATMENT OF INTERVERTEBRAL DISC DEGENERATION
#6818NEURAL STEM CELL COMPOSITIONS INCLUDING CHIMERIC POXVIRUSES FOR CANCER TREATMENT
#6819Innate Targeting of Adoptive Cellular Therapies
#6820CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#6821IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT
#6822DEFIBROTIDE FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD)
#6823Prodrugs of fused-bicyclic C5aR antagonists
#68249-Aminomethyl Minocycline Compounds And Use Thereof In Treating Community-Acquired Bacterial Pneumonia (CABP)
#6825METHODS OF TREATING BACTERIAL INFECTIONS WITH MINOCYCLINE
#6826Pharmaceutical formulation
#6827COMPOUNDS FOR TREATING ALZHEIMER'S DISEASE
#6828Stable aqueous capsaicin injectable formulations and medical uses thereof
#6829Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases
#6830Nanoparticle delivery systems
#6831BIO-REMEDIAL NON-IMMUNOGENIC CANNABINOID DELIVERY
#6832Apparatus and method for protecting neurons and reducing inflammation and scarring
#6833B CELLS GENETICALLY ENGINEERED TO SECRETE FOLLISTATIN AND METHODS OF USING THE SAME TO TREAT FOLLISTATIN-RELATED DISEASES, CONDITIONS, DISORDERS AND TO ENHANCE MUSCLE GROWTH AND STRENGTH
#6834FOETAL POLYMIX OF MESENCHYMAL STEM CELLS UNDER HYPOXIC CONDITIONS FOR THE TREATMENT OF CLINICAL DISORDERS AND DISEASES
#6835INJECTABLE OFF-THE- SHELF CARTILAGE, TENDON, AND LIGAMENT REPAIR COMPOSITIONS AND METHODS OF USE
#6836SUBCUTANEOUS DOSING OF ANTI-CD38 ANTIBODIES
#6837Pharmaceutical Composition for Cancer Treatment
#6838TREATMENT OF OVARIAN CANCER WITH ANTI-CD47 AND ANTI-PD-L1
#6839Materials and methods for treating Friedreich's Ataxia
#6840MODIFIED CYTOTOXINS AND THEIR THERAPEUTIC USE
#6841Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists
#6842Ambrisentan for use in the treatment of acute renal failure
#6843HIGH CONCENTRATION ANTI-C5 FORMULATIONS
#6844RSV RNA vaccines
#6845OCA-B peptide conjugates and methods of treatment
#6846BIFUNCTIONAL BLOOD BRAIN THERAPIES
#6847METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#6848Pharmaceutical composition, food composition and food additive for preventing, alleviating or treating muscle loss, weakness and atrophy, containing, as active ingredient, , culture liquid thereof or dead cells thereof
#6849COMPOSITIONS AND METHODS FOR TREATING PAIN
#6850Treatment of breast cancer using combination therapies comprising an ATP competitive AKT inhibitor, a CDK4/6 inhibitor, and fulvestrant
#6851TETRACYCLIC COMPOUNDS AND THEIR SALTS, COMPOSITIONS, AND METHODS FOR THEIR USE
#6852PHARMACEUTICAL COMBINATION FOR MOOD DISORDERS
#6853Intrathecal administration of levetiracetam
#6854Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
#6855LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE
#6856Injection for Protecting Ischemic Myocardium and Preparation Method thereof
#6857Sustained release olanzapine formulations
#6858Amino-pyrimidine skeletal muscle modulators
#6859Hydrolyzed pea protein-based nutrient composition
#6860Chimeric antigen receptor t-cells expressing interleukin-8 receptor
#6861Method of fixing and expressing physiologically active substance
#6862Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
#6863P-boronophenylalanine derivative and composition containing same, and kit for producing said derivative and composition
#6864Methods of treating prostate cancer with an anti-PSMA/CD3 antibody
#6865Treating refractory migraine
#6866Treating refractory migraine
#6867Immunogenic compositions comprising surface proteins and uses thereof
#6868Heterotandem bicyclic peptide complex
#6869C17 POLAR-SUBSTITUTED HETEROAROMATIC SYNTHETIC TRITERPENOIDS AND METHODS OF USE THEREOF
#6870OXYSTEROLS AND METHODS OF USE THEREOF
#6871DRUGS TO TREAT OCULAR DISORDERS
#6872Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
#6873Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
#6874CONJUGATION OF TLR7 AGONIST TO NANO-MATERIALS ENHANCES THE AGONISTIC ACTIVITY
#6875Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
#6876BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#6877Method for stabilizing a toxin
#6878Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)
#6879Pre-mixed, ready-to-use pharmaceutical compositions
#6880Cancer treatment combinations
#6881Vaccine compositions comprising a water-in-oil emulsion, immunogen-loaded hydrogel particles, and cationic polymer
#6882Lipidated immune response modifier compound compositions, formulations, and methods
#6883FORMATION OF BONE
#6884TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
#6885Heparin-Associated Polypeptides and Uses Thereof
#6886PROMOTING EPITHELIAL REGENERATION USING HEPARIN BINDING EPIDERMAL GROWTH FACTOR LIKE GROWTH FACTOR
#6887Compositions and Methods for Cancer Immunotherapy
#6888Therapeutic pooled blood apoptotic cell preparations and uses thereof
#6889Method for Producing an Exosome Containing Agent for Metastasis Suppression
#6890Immune modulation with TLR9 agonists for cancer treatment
#6891NANOPARTICLE COMPOSITIONS
#6892Use of extract in the preparation of drugs for treatment of viral and/or bacterial diseases
#6893USES OF PULSATILLA CHINENSIS EXTRACT IN PREPARING DRUG FOR TREATING VIRAL AND/OR BACTERIAL DISEASES
#6894Pharmaceutical compositions
#6895Increasing Cancer Cells' Sensitivity to Tumor Treating Fields (TTFields) by Inhibiting IL11 Activity
#6896THIOREDOXIN REDUCTASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER
#6897METHODS FOR SCAR PREVENTION
#6898Organoarsenic compounds and methods for the treatment of cancer
#6899Organoarsenic compounds and methods for the treatment of cancer
#6900Methods for the treatment of leptomeningeal disease